Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ERT, a provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations, has been selected by pharmaceutical firms to provide multi-mode electronic patient reported outcomes (ePRO) devices and services.
Subscribe to our email newsletter
ERT offers centralized cardiac safety and respiratory efficacy services in drug development and also collects, analyzes and distributes ePRO in multiple modalities across all phases of clinical research.
A specialty division of a pharmaceutical company has awarded $7m contract to ERT to manage a suite of studies using ERT’s proprietary VIAPhone platform over the next three years.
ERT will also provide VIAPen solution for a pivotal Phase III program, under a $3m contract.
ERT will also allow a pharma company to use its VIAPhone Pain Diary for a Phase III clinical trial, along with VIAPen solution for site assessments, as part of a $1.2m contract.